BIOS Fund III, LP

CIK: 0001791917

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)13 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ACTU

ACTUATE THERAPEUTICS, INC.

Director10% Owner

Discretionary Trading P&L

Holdings

Transaction History (13 total)

ACTU
ACTUATE THERAPEUTICS, INC.
Oct 28, 2026
Award(A)
Warrant (Right to Buy)
Indirect
65K shares-
ACTU
ACTUATE THERAPEUTICS, INC.
Oct 28, 2026
Award(A)
Warrant (Right to Buy)
Indirect
87.7K shares-
ACTU
ACTUATE THERAPEUTICS, INC.
Oct 28, 2026
Award(A)
Warrant (Right to Buy)
Indirect
682.9K shares-
ACTU
ACTUATE THERAPEUTICS, INC.
Oct 28, 2026
Award(A)
Warrant (Right to Buy)
Indirect
195K shares-
ACTU
ACTUATE THERAPEUTICS, INC.
Oct 28, 2026
Award(A)
Warrant (Right to Buy)
Indirect
368.3K shares-
ACTU
ACTUATE THERAPEUTICS, INC.
Oct 28, 2026
Award(A)
Warrant (Right to Buy)
Indirect
48K shares-
ACTU
ACTUATE THERAPEUTICS, INC.
Oct 28, 2026
Award(A)
Warrant (Right to Buy)
Indirect
82K shares-
ACTU
ACTUATE THERAPEUTICS, INC.
Oct 28, 2026
Award(A)
Warrant (Right to Buy)
Indirect
36.1K shares-
ACTU
ACTUATE THERAPEUTICS, INC.
Oct 28, 2026
Award(A)
Warrant (Right to Buy)
Indirect
269.3K shares-
ACTU
ACTUATE THERAPEUTICS, INC.
Oct 28, 2026
Award(A)
Warrant (Right to Buy)
Indirect
82.5K shares-
ACTU
ACTUATE THERAPEUTICS, INC.
Oct 28, 2026
Award(A)
Warrant (Right to Buy)
Indirect
133.1K shares-
ACTU
ACTUATE THERAPEUTICS, INC.
Oct 28, 2026
Award(A)
Warrant (Right to Buy)
Indirect
824K shares-
ACTU
ACTUATE THERAPEUTICS, INC.
Oct 28, 2026
Award(A)
Warrant (Right to Buy)
Indirect
126.2K shares-

		Type	Shares	Price		Ownership
Oct 28, 2026	ACTU ACTUATE THERAPEUTICS, INC.	Award(A) Warrant (Right to Buy)	64,995	-	-	Indirect
Oct 28, 2026	ACTU ACTUATE THERAPEUTICS, INC.	Award(A) Warrant (Right to Buy)	87,743	-	-	Indirect
Oct 28, 2026	ACTU ACTUATE THERAPEUTICS, INC.	Award(A) Warrant (Right to Buy)	682,885	-	-	Indirect
Oct 28, 2026	ACTU ACTUATE THERAPEUTICS, INC.	Award(A) Warrant (Right to Buy)	194,984	-	-	Indirect
Oct 28, 2026	ACTU ACTUATE THERAPEUTICS, INC.	Award(A) Warrant (Right to Buy)	368,304	-	-	Indirect
Oct 28, 2026	ACTU ACTUATE THERAPEUTICS, INC.	Award(A) Warrant (Right to Buy)	47,972	-	-	Indirect
Oct 28, 2026	ACTU ACTUATE THERAPEUTICS, INC.	Award(A) Warrant (Right to Buy)	82,018	-	-	Indirect
Oct 28, 2026	ACTU ACTUATE THERAPEUTICS, INC.	Award(A) Warrant (Right to Buy)	36,056	-	-	Indirect
Oct 28, 2026	ACTU ACTUATE THERAPEUTICS, INC.	Award(A) Warrant (Right to Buy)	269,342	-	-	Indirect
Oct 28, 2026	ACTU ACTUATE THERAPEUTICS, INC.	Award(A) Warrant (Right to Buy)	82,454	-	-	Indirect
Oct 28, 2026	ACTU ACTUATE THERAPEUTICS, INC.	Award(A) Warrant (Right to Buy)	133,073	-	-	Indirect
Oct 28, 2026	ACTU ACTUATE THERAPEUTICS, INC.	Award(A) Warrant (Right to Buy)	824,012	-	-	Indirect
Oct 28, 2026	ACTU ACTUATE THERAPEUTICS, INC.	Award(A) Warrant (Right to Buy)	126,162	-	-	Indirect

1-13 of 13 transactions

About BIOS Fund III, LP

BIOS Fund III, LP (SEC CIK 0001791917) files insider reports with the SEC as Director of ACTUATE THERAPEUTICS, INC. (ACTU).

Signal8 holds 1 ownership filing by BIOS Fund III, LP, a Form 4, filed on Oct 30, 2026. Those filings report 13 transactions, the latest on Oct 28, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on BIOS Fund III, LP's filings is in FORT WORTH, TX.

Recent filings by BIOS Fund III, LP

Oct 28, 2026: Grants or awards of ACTU derivative securities (13 lines, Form 4, code A).

Other insiders filing for ACTUATE THERAPEUTICS, INC. (ACTU)

THOMSON TODD S, Director
BIOS Fund I, LP, Director
SCHMITT DANIEL M, President, CEO and Director
Zabrowski Dan, Director
Sawhney Roger, Director
RONNEBERG AMY L, Director

How to read Form 4 transaction codes